The Excedr Blog
Enhance your lab operations and funding strategies with actionable advice on equipment leasing, financing, procurement, and life sciences industry trends.
Cartography Biosciences Secures $67 Million Series B to Advance Precision Immunotherapy
Cartography Biosciences secures $67M Series B to advance precision cancer immunotherapies—Excedr covers this major biotech funding round.
October 2025
Axon Therapies: Revolutionizing Heart Failure Treatment Through Splanchnic Ablation
Axon Therapies pioneers a breakthrough in heart failure treatment with splanchnic nerve ablation—Excedr covers this major biotech funding round.
September 2025
Star Therapeutics: Developing Antibody Therapies for Rare Blood Disorders
Star Therapeutics advances antibody therapies for rare blood disorders—Excedr covers this major biotech funding round.
September 2025
Avenzo Therapeutics Raises Capital to Transform Cancer Treatment
Avenzo Therapeutics raises $60M Series B to advance next-gen cancer therapies—Excedr covers this major biotech funding round announcement.
September 2025
How Preclinical Biotechs Scale with Equipment Leasing
How do preclinical biotech startups scale faster with equipment leasing? By preserving cash, reducing upfront costs, allowing them to hit milestones sooner.
September 2025
Ollin Biosciences Emerges from Stealth with $100M to Advance Vision Therapies
Ollin Biosciences launches with $100M Series A to develop breakthrough vision therapies—Excedr covers this major biotech funding round announcement.
September 2025
Top Equipment Needs in AI-Driven Drug Discovery Labs
What types of lab equipment are needed to support AI-driven drug discovery? Learn how to scale smartly with flexible, cost-effective procurement strategies.
September 2025